| Heading: |
Epilepsy: Drugs |
| Question ID: |
1804969 |
| UIN: |
53930 |
| House: |
Commons |
| Date tabled: |
2025-05-21 |
| Asking Member ID: |
4519 |
| Asking Member display name: |
James Cartlidge
|
| Asking Member handle: |
jcartlidgemp
|
| Asking Member Twitter reference: |
@jcartlidgemp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of barriers to regular access to prescribed medication on people with epilepsy. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are a range of anti-seizure medications that have been recommended by the National Institute for Health and Care Excellence (NICE) as effective in the treatment of epilepsy. NICE guidance outlines that clinicians should develop an individualised ant... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |